Safe use of opioids in chronic noncancer pain

Cleveland Clinic Journal of Medicine

Volumn 71, Issue 11, 2004, Pages 897-904

  Dews, Teresa E ^a   Mekhail, Nagy ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BUPRENORPHINE; BUTORPHANOL; CODEINE; DEXTROPROPOXYPHENE; DEZOCINE; FENTANYL; HYDROCODONE; HYDROMORPHONE; LAXATIVE; LEVORPHANOL; METHADONE; MORPHINE; NALBUPHINE; NARCOTIC ANALGESIC AGENT; OPIATE; OXYCODONE; PARACETAMOL; PENTAZOCINE; PETHIDINE;

ABDOMINAL CRAMP; ANXIETY DISORDER; CANCER PAIN; CHILL; CHRONIC PAIN; CONSTIPATION; DEPRESSION; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; DYSPHORIA; FATIGUE; FEAR; HUMAN; HYPERTENSION; HYPERTHERMIA; HYPOTENSION; INSOMNIA; IRRITABILITY; LACRIMAL GLAND DISEASE; MEDICAL DOCUMENTATION; MIOSIS; MYDRIASIS; MYOCLONUS; NAUSEA AND VOMITING; OPIATE ADDICTION; PAIN ASSESSMENT; PATIENT SELECTION; PHYSICIAN ATTITUDE; PRESCRIPTION; PRURITUS; QUALITY OF LIFE; RESPIRATION DEPRESSION; REVIEW; RHINORRHEA; SEIZURE; SEXUAL DYSFUNCTION; SIDE EFFECT; SOMNOLENCE; SUBSTANCE ABUSE; TACHYCARDIA; TREMOR; URINE RETENTION; WITHDRAWAL SYNDROME;

EID: 8844239147     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.71.11.897     Document Type: Review

References (24)

1. Way EL. History of opiate use in the Orient and the United States. Ann N Y Acad Sci 1982; 398:12-23.
2. Garcia J, Altman RD. Chronic pain states: pathophysiology and medical therapy. Semin Arthritis Rheum 1997; 27:1-16.
3. Brescia FJ, Adler D, Gray G, Ryan MA, Cimino J, Mantani R. A profile of hospitalized advanced cancer patients. J Pain Symptom Manage 1990; 5:221-227.
4. Cleeland CS, Gonin R, Hatfield AK, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 1994; 330:592-596.
5. Portenoy RK. Current pharmacotherapy of chronic pain. J Pain Symptom Manage 2000; 19(suppl 1):S16-S20.
6. Aronoff GM. Opioids in chronic pain management: Is there a significant risk of addiction? Curr Rev Pain 2000; 4:112-121.
7. Jamison RN, Anderson KO, Peeters-Asdourian C, Ferrante FM. Survey of opioid use in chronic non-malignant pain patients. Reg Anesth 1994; 19:225-230.
8. www.cancer.gov/cancertopics/pdq/supportivecare/substanceabuse/health professional. Last accessed August 20, 2004.
9. Hsu MM, Wong CS. The roles of pain facilitatory systems in opioid tolerance. Acta Anaesthesiol Sin 2000; 38:155-166.
10. Fishman SM, Wilsey B, Yang J, Reisfield GM, Bandman TB, Borsook D. Adherence monitoring and drug surveillance in chronic opioid therapy. J Pain Symptom Manage 2000; 20:293-307.
11. Finch PM, Roberts LJ, Price L, Hadlow NC, Pullan PT. Hypogonadism in patients treated with intrathecal morphine. Clin J Pain 2000; 16:251-254.
12. Bannwarth B. Risk-benefit assessment of opioids in chronic noncancer pain. Drug Saf 1999; 21:283-296.
13. Jamison RN, Kauffman J, Katz NP. Characteristics of methadone maintenance patients with chronic pain. J Pain Symptom Manage 2000; 19:53-62.
14. National Institutes of Health. Symptom management in cancer pain, depression, and fatigue: State of the Science Conference. J Pain Palliat Care Pharmacother 2003; 17:77-97.
15. Savage S. Opioid use in the management of chronic pain. Med Clin North Am 1999; 83:761-786.
16. Inturrisi CE. Clinical pharmacology of opioids for pain. Clin J Pain 2002; 18(suppl 4):S3-S13.
17. Mao J. NMDA and opioid receptors: their interactions in antinociception, tolerance, and neuroplasticity. Brain Res Brain Res Rev 1999; 30:289-304.
18. Smith MT. Neuroexcitatory effects of morphine and hydromorphone: evidence implicating the 3-glucuronide metabolites. Clin Exp Pharmacol Physiol 2000; 27:524-528.
19. Mercadante S. Opiaid rotation for cancer pain: rationale and clinical aspects. Cancer 1999; 86:1856-1866.
20. Snyder SH, Pasternak GW. Historical review: opioid receptors. Trends Pharmacol Sci 2003; 24:198-205.
21. Kroin JS. Intrathecal drug administration. Present use and future trends. Clin Pharmacokinet 1992; 22:319-326.
22. Payne R, Gradert TL, Inturrisi CE. Cerebrospinal fluid distribution of opioids after intraventricular and lumbar subarachnoid administration in sheep. Life Sci 1996; 59:1307-1321.
23. Paice JA, Winkelmuller W, Burchiel K, et al. Clinical realities and economic considerations: efficacy of intrathecal pain therapy. J Pain Symptom Manage 1997; 14:S14-S26.
24. Rawal N. Epidural and spinal agents for postoperative analgesia. Surg Clin North Am 1999; 79:313-344.